Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001140361-14-031792
Filing Date
2014-08-11
Accepted
2014-08-11 17:03:49
Documents
9
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 ASTERIAS BIOTHERAPEUTICS, INC 10-Q 6-30-2014 form10q.htm 10-Q 586051
2 EXHIBIT 31 ex31.htm EX-31 22312
3 EXHIBIT 32 ex32.htm EX-32 5412
  Complete submission text file 0001140361-14-031792.txt   4265881

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT ast-20140630.xml EX-101.INS 459284
5 XBRL TAXONOMY EXTENSION SCHEMA ast-20140630.xsd EX-101.SCH 35549
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ast-20140630_cal.xml EX-101.CAL 53051
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ast-20140630_def.xml EX-101.DEF 138378
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE ast-20140630_lab.xml EX-101.LAB 501261
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ast-20140630_pre.xml EX-101.PRE 277128
Mailing Address 230 CONSTITUTION DRIVE MENLO PARK CA 94025
Business Address 230 CONSTITUTION DRIVE MENLO PARK CA 94025 510-521-3390
Asterias Biotherapeutics, Inc. (Filer) CIK: 0001572552 (see all company filings)

EIN.: 461047971 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55046 | Film No.: 141031370
SIC: 2836 Biological Products, (No Diagnostic Substances)